News/ News/ Oncology Y-mAbs claims FDA OK for neuroblastoma drug Danyelza Phil Taylor antibody, Danyelza, neuroblastoma, Oncology, Y-mAbs Therapeutics 0 Comment Y-mAbs Therapeutics has claimed its first product approval, getting a green light from the FDA for Danyelza for Share X Y-mAbs claims FDA OK for neuroblastoma drug Danyelza https://pharmaphorum.com/news/y-mabs-claims-fda-ok-for-neuroblastoma-drug-danyelza/